Grants to Pennsylvania government agencies and police departments to address law enforcement issues related to medical marijuana. Applicants must complete the required registrations prior to submitting an application. Funding is intended for activities that include, but are not limited to, training for drug recognition experts; education, training, and awareness programs; and other enforcement projects.
Funds for the proposed program shall be used to support one or more of the following:
Drug Recognition Experts (DRE) training:
Funds may be used to reimburse agencies for overtime to fill required shifts while other officers are attending this training. Funds may also be used for other expenses relating to training, including, but not limited to, travel expenses as appropriate.
Please note: There are prerequisites required for participation in DRE training including certification as a Standardized Field Sobriety Testing (SFST) Practitioner and SFST Instructor along with completion of Advanced Roadside Impaired Driving Enforcement (ARIDE) Training. For a full listing of prerequisites and application requirements, please review the information on the PA DUI Association TEAM DUI website: https://www.padui.org/
Education, training, and awareness programs:
Funds may be used for costs related to training focused on the enforcement of the Medical Marijuana Act. Examples of eligible expenses include, but are not limited to:
Training or conference registration costs, and overtime reimbursement to agencies to offset the costs of overtime for officers required to fill shifts while other officers are attending training;
Standardized Field Sobriety Testing (SFST) Practitioner training;
Standardized Field Sobriety Testing (SFST) Instructor training;
Purchase of field-testing equipment to establish prima facia measures;
Support activities to reduce criminal activity directed against legitimate persons purchasing medical marijuana near a licensed, jurisdictional facility; and
Costs related to forensic testing of intoxicants.
Other Enforcement Activities:
Reimbursement of overtime costs for required court appearances by law enforcement officers related to medical marijuana cases;
Pilot data-sharing projects for multi-jurisdictions to collect and share data relating to the enforcement of the Medical Marijuana Act;
Strategies to combat the distribution of medical marijuana to unauthorized persons.
Eligible applicants are municipalities and regional police departments proposing to implement projects and programs that directly address the enforcement of the Medical Marijuana Act.
Applicants must be in good standing with PCCD to be eligible for these funds. The applicant and recipient agencies’ historical success in implementing PCCD-funded programs/initiatives that met their intended goals will be considered in the review process.
Ineligible
The following items are not eligible for funding and may result in an administrative rejection of the application:
- RADAR/LIDAR;
- Funds may not be used directly or indirectly for security enhancements or equipment for nongovernmental entities not engaged in criminal justice or public safety and good order.
Pre-Application Information
- Recommended Egrants Agency Registration Date: September 1, 2023
- Recommended Egrants User Registration Date: Tuesday, September 14, 2023
- Mandatory Egrants Application Deadline: Tuesday, September 21, 2023, 11:59 PM.
Questions should be received by the close of business on Wednesday, September 18, 2023.
Direct questions to RA-CD-OCJSI@pa.gov with “Medical Marijuana Act Enforcement” in the subject line.
Questions concerning the Egrants System should be made directly to the Egrants Help Desk at either (717) 787-5887, or you may call toll-free at (800) 692-7292 and select option 9 and then option 6 when prompted, or by email at RA-egrantssupport@pa.gov.
Before starting your grant application, please review the funding source's website listed below for updates / changes / addendums / conferences / LOIs.
We use cookies to enhance your browsing experience on GrantWatch.com. By continuing to use our site, you consent to the use of cookies. Learn more by exploring our comprehensive Cookie Policy
